Owner Scorecard


← All companies ← OFG Manual OGE → ← NVST Medical Devices & Equipment OMCL →

OFIX, Orthofix Medical Inc. Common Stock (DE)

Medical Devices & Equipment consumer brand Unprofitable

Orthofix is a global medical technology company headquartered in Lewisville, Texas.

By providing medical technologies that heal musculoskeletal pathologies, Orthofix delivers exceptional experiences and life-changing solutions to patients around the world.

Orthofix offers a comprehensive portfolio of spinal hardware, bone growth therapies, limb reconstruction solutions, biologics and enabling technologies, including the 7D FLASH Navigation System.

Latest annual: FY2025 10-K
OFIX · Orthofix Medical Inc. Common Stock (DE)
I

The business

What it sells, where the money comes from, the kind of company it is.

Revenue · FY2025
$822M
+2.9% YoY · 15% 5-yr CAGR
Vital signs · TTM, with 5-yr average
Revenue $833M 5-yr avg $659M
Gross margin 71% 5-yr avg 70%
Operating margin −4.7% 5-yr avg −8.8%
ROIC −6% 5-yr avg −9%
Owner-earnings margin −3% 5-yr avg −4%
Free cash flow margin −3% 5-yr avg −4%

Next report Est. 11/2–11/6 · the 10-Q for the quarter ended late September · due within 40 days of period end · has filed ~36 days after · the wire records it on arrival

The business in brief

read the 10-K →

What this business is and what moves its needle, from its own SEC filings.

What it is
Revenue is Global Spine (84%) and Global Limb Reconstruction (16%).
Situation
Unprofitable. No sustained operating profit across the record; an earnings multiple has nothing to rest on. What the record does show is revenue, the gross-margin trajectory, and the burn against the cash on hand.
What moves the needle
Operating margin has run around −2.3% through the cycle on a 75% gross margin, the operating line in the red even at its best — so the lever is whether the spending below the gross line can come down enough to clear a profit: revenue growth against the cost curve, and the cash runway until it does. Inventory runs near 19% of sales, so how fast it turns back into cash — and the risk of writing it down when demand softens — sits alongside the margin. Read this kind of business on the installed base and what follows it. On its own account, the filing leans hardest on pricing power & competition, set against the numbers in what the filing emphasizes, below.
Is it a good business?
Return on capital has rarely cleared the cost of capital (median −3%, above 15% in 0 of 10 years). Owner earnings, the cash-based check, have been thin too. This is price-taker territory, where the balance sheet and the cycle matter more than any multiple; the rest is in the 10-K.

Every line is arithmetic on the company's filings, shown in full in the sections below.

Where the money comes from

read the 10-K →

Global Spine is 84% of revenue, with Global Limb Reconstruction the other meaningful segment at 16%.

Revenue by reportable segment, FY2025
  • Global Spine84%$688M
  • Global Limb Reconstruction16%$135M
By geographyUnited States83%Others9%Italy3%United Kingdom2%France1%Germany1%Brazil1%

From the segment footnote of the company's own 10-K. Shares are of total revenue; the profit bar shows each segment's share of segment operating profit, before unallocated corporate costs.

II

The record

Ten years of arithmetic, read across the cycle.

The record, 2016–2025

realized figures from each filing · older years to the left
2016’162017’172018’182019’192020’202021’212022’222023’232024’242025’25TTMTTMJun 2026
Income statement
$410M$434M$453M$460M$407M$464M$461M$747M$799M$822M$833MRevenueRevenue
$322M$341M$356M$359M$305M$350M$337M$486M$546M$566M$594MGross profitGross prof.
79%79%79%78%75%75%73%65%68%69%71%Gross marginGross mgn
63%62%64%67%67%63%67%71%67%67%67%SG&A / revenueSG&A/rev
7%7%7%8%10%11%11%11%9%8%7%R&D / revenueR&D/rev
$21M$41M$30M($19M)($6M)($8M)($13M)($139M)($85M)($81M)($39M)Operating incomeOp. inc.
5.1%9.4%6.6%−4.1%−1.5%−1.8%−2.9%−18.6%−10.6%−9.9%−4.7%Operating marginOp. mgn
$19M$36M$23M($27M)($368K)($13M)($18M)($149M)($124M)($91M)Pretax incomePretax
$3M$6M$14M($28M)$3M($38M)($20M)($151M)($126M)($92M)($62M)Net incomeNet inc.
Cash flow & returns
$59M$39M$50M$32M$74M$18M($12M)($46M)$26M$33M$16MOperating cash flowOp. cash
$21M$20M$19M$25M$31M$30M$29M$53M$60M$77M$53MDepreciation & amortizationD&A
$19M$68K($1M)$14M$25M$12M($39M)$17M$59M$20M($3M)Working capital & otherWC & other
$16M$15M$14M$19M$15M$18M$21M$60M$35M$35M$44MCapexCapex
4.0%3.4%3.0%4.1%3.8%3.8%4.6%8.1%4.4%4.2%5.3%Capex / revenueCapex/rev
$43M$24M$36M$13M$59M$690K($33M)($106M)($9M)($1M)($28M)Owner earningsOwner earn.
10.4%5.6%8.0%2.8%14.5%0.1%−7.1%−14.2%−1.1%−0.2%−3.3%Owner earnings marginOE mgn
$43M$24M$36M$13M$59M$690K($33M)($106M)($9M)($1M)($28M)Free cash flowFCF
10.4%5.6%8.0%2.8%14.5%0.1%−7.1%−14.2%−1.1%−0.2%−3.3%Free cash flow marginFCF mgn
$44M$18M$18MAcquisitionsAcquis.
($22M)($16M)($61M)($23M)($52M)($23M)($25M)($33M)($28M)($35M)Investing cash flowInv. cash
($46M)$4M$3M($11M)$3M($4M)($78K)$65M$51M($786K)Financing cash flowFin. cash
($739K)$1M($881K)($207K)$1M($815K)($997K)$619K($938K)$1MExchange-rate effectFX
($10M)$27M($9M)($2M)$26M($9M)($37M)($13M)$48M($623K)Change in cashΔ cash
5%9%7%-6%-2%-3%-4%-17%-12%-12%-6%ROICROIC
1%2%4%-9%1%-11%-6%-25%-25%-20%-14%Return on equityROE
1%2%4%−9%1%−11%−6%−25%−25%−20%−14%Retained to equityRetained/eq
Balance sheet
$40M$81M$70M$70M$96M$88M$51M$33M$83M$82M$104MCash & investmentsCash+inv
$58M$63M$78M$87M$72M$79M$83M$128M$135M$136M$136MReceivablesReceiv.
$63M$81M$77M$82M$85M$83M$100M$222M$189M$172M$184MInventoryInvent.
$14M$18M$18M$20M$23M$26M$28M$58M$49M$58M$64MAccounts payablePayables
$107M$127M$137M$149M$134M$135M$155M$292M$275M$250M$257MOperating working capitalOper. WC
$194M$252M$245M$261M$270M$270M$256M$420M$433M$417M$446MCurrent assetsCur. assets
$83M$79M$86M$85M$104M$106M$84M$165M$169M$170M$157MCurrent liabilitiesCur. liab.
2.3×3.2×2.8×3.1×2.6×2.5×3.1×2.5×2.6×2.4×2.8×Current ratioCurr. ratio
$49M$45M$43M$63M$64M$59M$58M$159M$140M$129MNet PP&ENet PP&E
$54M$54M$72M$71M$84M$71M$71M$195M$195M$195M$195MGoodwillGoodwill
$372M$405M$467M$496M$526M$477M$459M$925M$893M$851M$873MTotal assetsAssets
$94M$157M$157M$222MTotal debtDebt
$61M$74M$75M$118MNet debt / (cash)Net debt
$109M$109M$131M$168M$169M$140M$122M$327M$390M$401MTotal liabilitiesTotal liab.
$263M$297M$335M$328M$357M$337M$337M$599M$503M$450M$429MShareholders’ equityEquity
3.9%2.9%4.2%4.7%4.0%3.3%4.0%4.8%4.1%3.5%3.4%Stock comp / revenueSBC/rev
Per share
18.5M18.5M18.9M18.9M19.4M19.7M20.1M36.7M38.1M39.6M40.7MShares out (diluted)Shares
$22.19$23.45$23.96$24.33$20.97$23.59$22.97$20.33$20.97$20.76$20.48Revenue / shareRev/sh
$0.17$0.34$0.73$-1.51$0.13$-1.95$-0.98$-4.12$-3.30$-2.33$-1.52EPS (diluted)EPS
$2.31$1.31$1.92$0.69$3.03$0.04$-1.64$-2.89$-0.24$-0.03$-0.68Owner earnings / shareOE/sh
$2.31$1.31$1.92$0.69$3.03$0.04$-1.64$-2.89$-0.24$-0.03$-0.68Free cash flow / shareFCF/sh
$0.89$0.79$0.72$1.00$0.80$0.90$1.07$1.64$0.91$0.87$1.08Cap. spending / shareCapex/sh
$14.27$16.03$17.73$17.33$18.40$17.11$16.80$16.30$13.19$11.36$10.55Book value / shareBVPS

The diluted share count moved ×1.83 into 2023 — shares issued, not a split the totals corroborate — and the per-share figures carry the counts as filed.

Per-share growththe realized rate an owner's share compounded
9-yr5-yr
Revenue / share−0.7%/yr−0.2%/yr
Capital spending / share−0.2%/yr+1.8%/yr
Book value / share−2.5%/yr−9.2%/yr

Where the cash went

ReinvestBuybacksDividendsAcquisitionsRetainedBeyond op. cash

Each year's outlays against its operating cash: the mix, and how it drifts. The hatched cap is spending beyond that year's operating cash — financed from the balance sheet or borrowing, not operations.

FY2016FY2025

Net income is the accountant's number; owner earnings is the cash an owner could take out. The walk between them, off the cash-flow statement, and whether the gap is widening or holding.

In fiscal 2025 the business turned a $92M loss into ($1M) of owner earnings: more cash than the profit line showed, after the non-cash charges and the capital it put back in.

FY2025FY2024FY2023FY2022FY2021
Reported net income($92M)($126M)($151M)($20M)($38M)
Depreciation & amortizationnon-cash charge added back+$77M+$60M+$53M+$29M+$30M
Stock-based compensationreal costnon-cash, but a real cost+$29M+$32M+$36M+$18M+$15M
Working capital & othertiming of cash in and out, other non-cash items+$20M+$59M+$17M−$39M+$12M
Cash from operations$33M$26M($46M)($12M)$18M
Capital expenditurecash put back in to keep running and to grow−$35M−$35M−$60M−$21M−$18M
Owner earnings($1M)($9M)($106M)($33M)$690K
Owner-earnings marginowner earnings ÷ revenue0%-1%-14%-7%0%

Owner earnings is the cash an owner could pull out without starving the business: operating cash less the capital it must spend to hold its position . The cash-flow statement also adds stock comp back as non-cash, but it is a real cost paid in shares; counted as the expense it is (less $29M), owner earnings is nearer ($30M).

Maintenance capex is estimated as depreciation where a growing business invests above it; free cash flow is the figure the scorecard's free-cash margin reads.

III

Quality & stewardship

Returns, the balance sheet, capital allocation, and pay.

Owner’s Scorecard

FY2025 10-K · source on SEC EDGAR →

Will it survive?

  • Interest expense not tagged in the data
    What this means

    No usable interest-expense line was tagged in the filing data, but the balance sheet carries real net debt — so the interest burden here is unknown, not absent. Read the debt on the net-debt check below.

  • Net debt against an operating loss
    Cash $82M − debt $157M
    What this means

    Netting $82M of cash and short-term investments against $157M of debt leaves $75M owed, with no operating profit this year to measure it against — understand that combination before anything else about the company. Net debt is the leverage figure that matters: the cash is already set against the debt. Strategic or illiquid investments aren't counted here.

  • Long (60+ days)
    DSO 60 + DIO 245 − DPO 83 days
    What this means

    Days cash is tied up between paying suppliers and collecting from customers. Lower is better; a long cycle means growth itself eats cash.

Is it a good business?

  • Below average through the cycle
    10-yr median, range -17%–9%; -12% latest = NOPAT ($64M) ÷ invested capital $525M
    Industry peers: median -23%
    What this means

    The rate the business earns on the money tied up in it, Buffett's north star, because over time a stock tracks the ROIC beneath it. Above ~15% sustained hints at a moat; a return below the cost of capital (~8%) erodes value as a business grows rather than building it — the test Buffett weighs most. The headline is the median of the last 10 years (it ran -12% most recently), so one peak or trough year doesn't set the verdict. Asset-light businesses (R&D expensed, little capital) read artificially high, pair this with Owner Earnings.

  • Thin through the cycle
    10-yr median margin, range -14%–14%; latest ($1M) = operating cash $33M − maintenance capex $35M
    Industry peers: median -8%
    What this means

    What an owner could take out without starving the business: operating cash less the maintenance capital it must spend to hold its position — Buffett's owner earnings. That's -0% of revenue this year, a 1% median across 10 years. Treating stock comp as the real expense it is (less $29M of SBC) leaves ($30M).

  • Loss, but cash-generative
    Net income ($92M) · cash from operations $33M
    What this means

    The company reported a net loss, so a conversion ratio isn't meaningful. What matters then is whether operations still threw off cash, here, they did.

How is the cash used?

  • Not enough data
    What this means

    The filing data didn't include the inputs for this check.

  • Investing or harvesting? 0.45×
    Harvesting
    Capex $35M ÷ depreciation & amortization as filed $77M
    What this means

    Descriptive, not a grade. Above ~1× means investing faster than assets wear out (growth, or, sustained for years, today's earnings carrying less depreciation than tomorrow's will). Below means spending less than it's wearing out (efficiency, or a melting asset base). The ratio won't tell you which; the filings will.

The promise and the pay packet

  • Is the buyback buying ownership, or mopping up? 3.5%
    Stock pay, share count unread
    Stock compensation $29M (fiscal 2025), 3.5% of revenue · no repurchases · the share count is not comparable across these years (a split or a first listing sits in the record), so the drift is withheld
    What this means

    Stock handed to employees is a real cost paid in the owner's own currency: it is charged against profit, but the shares it creates are permanent. Many companies repurchase stock at the same time, which looks like a return of capital and often is not — if the count barely moves, the cash merely cancelled the pay packet and bought the owner nothing. The three states worth telling apart are a count genuinely shrinking, a count standing still despite large repurchases, and a count rising because the issuance was never offset at all.

Graham’s defensive tests · 2 of 5 met

Graham’s numerical criteria for the defensive investor (The Intelligent Investor, ch. 14), run on the filings. A floor of safety, not a buy signal; many fine modern businesses fail his strictest liquidity rules by design.

  • Adequate size Miss
    Revenue ≥ $2B · $822M
    What this means

    Big enough to weather a storm. Graham's 1972 floor was ~$100M of sales (≈ $700M today); we use a $2B revenue line as a conservative modern stand-in.

  • Strong liquidity Pass
    Current ratio ≥ 2× · 2.45×
    What this means

    Current assets at least twice current liabilities, near-term bills covered without touching the business. Strict by design: many cash-rich modern firms run leaner and miss it, holding their cushion in longer-dated securities.

  • Conservative debt Pass
    Debt ≤ working capital · $157M vs $246M WC
    What this means

    Graham's rule that borrowings not exceed net current assets. Capital-heavy and buyback-heavy firms routinely fail it, read it next to interest coverage, not alone.

  • Earnings stability Miss
    A profit every year (10-yr record) · 6 loss years
    What this means

    Graham wanted earnings in each of the past ten years, the stability a defensive owner leans on.

  • Dividend record
    Uninterrupted dividends · no dividend line tagged in the data
    What this means

    An unbroken dividend was Graham's mark of durability. This record carries no dividends-paid line in any year — common for partnerships, whose distributions file under tags the chain doesn't read — so the criterion is withheld rather than judged on silence.

  • Earnings growth Miss
    Earnings +33% over the record · −1701%
    What this means

    At least a third more earnings than a decade ago, averaging three years at each end. Net income (not per-share), so stock splits don't distort it, buybacks and dilution show up in the share-count line instead.

  • Moderate price
    P/E ≤ 15 and P/E × P/B ≤ 22.5 · decided by the price
    What this means

    Graham's valuation gate, the wall he kept between a sound business and a sound investment. Three-year average earnings are $-3.02/share (latest year $-2.26), the averaged base the calculator's gate runs on, and book value is $11.05/share. Enter a price in “What the price implies” just below for the P/E, P/B, and whether it clears. But this is the rule Buffett outgrew: there's no hard P/E law, and a wonderful business can deserve a far richer multiple if the thesis holds, treat it as the bargain-hunter's floor, not a verdict on the price.

Durability & moat, 2016–2025

Whether the record’s returns held, and what the capital reinvested earned.

  • Profitable years 4 of 10
    What this means

    Lost money in 6 year(s), look at what happened there before trusting the average.

  • Return on capital ≥ 15% 0 of 3 yrs
    What this means

    A moat shows up as a high return on invested capital that holds year after year, not one good vintage.

  • Operating margin 7% → −13% (3-yr avg ends)
    What this means

    Through the cycle the operating margin slipped — about 7% early to −13% lately, median −3% — competition or costs are biting in.

  • Reinvestment, incremental ROIC returns capital
    What this means

    The capital base barely grew: this business returns cash through dividends and buybacks rather than reinvesting. Judge it on the cash returned, not on compounding.

  • Worst year 2023 · −18.6% op. margin
    What this means

    Operations went underwater in 2023, understand why before trusting the good years.

All figures as filed; the source filing is linked above.

Current Position

as of the latest quarter, Jun 30, 2026

Can the business pay what it owes this year, off the freshest balance sheet: the quality of the assets, the debt actually coming due, and what a low ratio means here.

Current assets$446M
  • Cash & short-term investments$104M
  • Receivables$136M
  • Inventory$184M
  • Other current assets$22M
Current liabilities$157M
  • Accounts payable$64M
  • Other current liabilities$93M
Current ratio2.84×all current assets ÷ what's due · Graham looked for 2×
Quick ratio1.67×stricter: inventory excluded
Cash ratio0.66×strictest: cash alone against what's due
Working capital$289Mthe cushion left after near-term bills
Revenue, latest quarter vs. a year ago+3.8%the freshest read on whether the business is still growing
Current ratio, recent quarters2.4× → 2.8×
Deeper floors
Tangible book value$168Mequity stripped of goodwill & intangibles
Net current asset value$2MGraham's net-net: current assets less all liabilities
Debt incl. operating leases$249M$27M of it operating leases

From the company's latest filing.

How the cash was used, 2016–2025

Over the record, the business generated $275M of operating cash; how management split it reads as a reinvestor, most operating cash is plowed back into the business.

  • Reinvested$248M · 90%
  • Buybacks$63M · 23%
  • Returned to owners$63M

    239% of the owner earnings the business produced over the span, $0 as dividends and $63M as buybacks.

  • Source of funding−$37M

    Reinvestment and shareholder returns ran $37M beyond the operating cash the business generated, so the gap was financed off the balance sheet.

  • Average price paid for buybacks$41.06

    Across the years where the filing reports a share count, 2M shares were bought for $63M, about $41.06 each.

  • Net change in share count120.3%

    The diluted count rose from 18M to 41M: issuance (stock pay, deals) outran any buybacks, so owners were diluted on net.

  • Dividend record

    No dividend line was reported in the filing data over the span; the record here neither confirms nor rules out a payout.

Buybacks are gross of stock issued to staff; the share-count line above is the net of that, the figure that decides whether owners gained. The average price paid blends a year of purchases (and any accelerated repurchase), so it is close, not exact. The record of where the cash went and on what terms.

Acquisitions & goodwill

from the balance sheet & the 10-year cash-flow record

Goodwill grows only when a company acquires and falls only when it concedes it overpaid. The size of that bet, the cash put into buying rather than building, and how much has already been written off.

Goodwill & intangibles$268M31% of all assets; the premium carried on the balance sheet for businesses acquired
Against book equity43%goodwill is this share of book equity; the rest is the company’s own retained and paid-in capital
Cash spent acquiring$68Mover 3 years since fiscal 2011 buying other businesses, against $248M of capital spent building over the 10-year record

$12M written down across 1 year (2021): goodwill the company has already conceded it overpaid for, charged against earnings. That is roughly 19% of the cash it put into acquisitions over the span. A write-down costs no cash (the cash went out when the deal was signed), but it is management marking its own past judgment to market.

Beside that spending sits $132M of cumulative amortization of acquired intangibles charged against earnings since fiscal 2009 — the purchase price of past deals, expensed over time. The cash figure above counts only cash consideration: goodwill of $195M against it says much of the buying was paid for in stock, which never passes through the cash-flow statement.

Goodwill, acquired intangibles and equity from the latest balance sheet; acquisition spend and amortization summed across the company's full tagged history, write-downs across the 10-year record, from the company's own filings.

Management, ownership & pay

read the proxy →

From the proxy: how much of the business the people running it own, and how they are paid.

  • Insider ownership2.7%

    The stake all directors and executive officers hold together, per the 2026 proxy: skin in the game, the first thing Munger reads.

  • Stock-based compensation$29M

    The slice of the business handed to employees in shares in fiscal 2025, 3.5% of revenue. Buffett's oldest accounting fight: this is compensation, compensation is an expense, real whether or not the headline earnings admit it. One trap: the cash-flow statement adds SBC back, so the operating cash, and the owner earnings drawn from it, are flattered by exactly this amount; counted as the cost it is, what an owner keeps is lower.

What an owner would ask, FY2025

read the 10-K →
  • Which reported numbers are a judgment call?
    Management names Stock compensation as critical estimates

    each rests partly on management's judgment; the filing's note sets out the assumptionsverify →

The questions the record and the charts do not answer on their own; each carries the figure and the place to look.

Peers, Medical Devices & Equipment

The same industry, side by side on owner economics. Each column names the period it is read over; the group median at the foot is the line to read each figure against.

CompanyRevenuelatest FY, USDGross marginmedian over the recordOp. marginmedian over the recordROICmedian over the recordOwner earn. marginmedian over the record
TNDMTandem Diabetes Care$1.0B52%-15.0%-24%-1%
INSPInspire Medical Systems$912M84%-28.7%-19%-23%
OFIXOrthofix Medical Inc. Common Stock (DE)$822M75%-2.3%-3%1%
ATECAlphatec Holdings$764M68%-30.2%-47%-31%
IRTCiRhythm Technologies$747M70%-25.5%-29%-13%
NVCRNovoCure$655M75%-19.4%-23%-5%
BVSBioventus Inc.$568M68%2.8%-3%7%
ATRCAtriCure$535M74%-10.8%-8%-8%
Group median72%-17.2%-21%-7%
IV

The price

What a price has to assume.

What the price implies

reverse-DCF

Type today's close and see the owner-earnings growth you'd have to believe to justify it, beside what Orthofix Medical Inc. Common Stock (DE) has delivered.

Orthofix Medical Inc. Common Stock (DE)’s latest year shows negative owner earnings, below the record’s own through-cycle owner earnings. So the tool opens on the through-cycle base, the cash it would earn at rest; clear the toggle below to read the latest year exactly as reported.

$

Through the cycle, Orthofix Medical Inc. Common Stock (DE) earns about $12M on its 1.5% median owner-earnings margin. This year’s −0.2% margin runs below that; the reported figure may understate a lean year. Normalize, below, values the price on that through-cycle figure rather than the latest year.

Base

The assumptions

9.0% = the 4.65% 10-year Treasury (Aug 19, 2026) + 4.35 points of equity premium. The rate you require is yours to set.

Enter a price above to run it.

Implied by the price
Owner-earnings growth, delivered
Owner-earnings yield
P/E (3-yr earnings ’23–’25)
P/B
Graham’s price gate

Graham capped the multiple at 15×; Buffett and Munger let that rule go: a wonderful business can deserve 50× if the thesis holds. The gate marks the bargain-hunter's floor.

Against a high-grade bond: Graham’s yardstick bond yield%

Prefilled with the 10-year Treasury (4.65%, as of Aug 19, 2026). Edit it for today’s exact figure, or a AAA corporate yield.

Graham measured a stock against the bond you could own instead, the heart of his margin of safety. Enter a price above to weigh the owner-earnings yield against this bond.

Free cash flow ($28M) on 41M shares outstanding, per the 10-Q cover, as of 2026-07-31; net debt $118M. The base opens on the through-cycle figure (the latest year sits off the record’s own median, and Graham’s averaging cuts both ways); clear Normalize to use the year as filed. Net of stock comp treats option pay as the expense it is. Capex ($44M) runs well above depreciation ($53M), so this is a build-out; Steady-state swaps total capex for maintenance (≈ depreciation), lifting the base to about ($18M), the cash it would throw off if it stopped expanding. The dials set the multiple a growth belief justifies; the price, and every dollar on this page, is yours.

Cite: Owner Scorecard, "Orthofix Medical Inc. Common Stock (DE) (OFIX), the owner's record," https://ownerscorecard.com/c/OFIX, data as of 2026-08-17.

Manual order: ← OFG its page in the Manual OGE →

Industry order: ← NVST the Medical Devices & Equipment chapter OMCL →